Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Non-Current Debt: 2022-2024

Historic Non-Current Debt for Immunocore Holdings (IMCR) over the last 3 years, with Dec 2024 value amounting to $391.0 million.

  • Immunocore Holdings' Non-Current Debt rose 0.54% to $392.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $392.6 million, marking a year-over-year increase of 0.54%. This contributed to the annual value of $391.0 million for FY2024, which is 714.42% up from last year.
  • According to the latest figures from FY2024, Immunocore Holdings' Non-Current Debt is $391.0 million, which was up 714.42% from $48.0 million recorded in FY2023.
  • Immunocore Holdings' Non-Current Debt's 5-year high stood at $391.0 million during FY2024, with a 5-year trough of $47.8 million in FY2022.
  • In the last 3 years, Immunocore Holdings' Non-Current Debt had a median value of $48.0 million in 2023 and averaged $162.3 million.
  • Data for Immunocore Holdings' Non-Current Debt shows a peak YoY skyrocketed of 714.42% (in 2024) over the last 5 years.
  • Immunocore Holdings' Non-Current Debt (Yearly) stood at $47.8 million in 2022, then increased by 0.43% to $48.0 million in 2023, then skyrocketed by 714.42% to $391.0 million in 2024.